RP-HPLC is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-02-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Identity and purity of semax are established with reversed-phase high-performance liquid chromatography coupled to ultraviolet detection, usually at 214 nanometres. Mass spectrometry, most often electrospray ionisation in positive mode, confirms the molecular mass and reveals truncated sequences. Amino acid analysis and peptide mapping after enzymatic digestion provide additional structural confirmation. Laboratories typically report purity as the percentage area of the main peak, a figure that does not capture isomeric or oxidised variants unless the method resolves them.
The peptide is prone to several degradation pathways. Oxidation of the methionine residue produces a sulfoxide that elutes close to the parent peak in many chromatographic systems. Hydrolysis of peptide bonds and deamidation of susceptible residues in related sequences also reduce purity over time. Lyophilised material kept dry at minus twenty degrees Celsius and shielded from light is the most stable form commonly described in laboratory practice.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Free acid form of the heptapeptide; depends on terminal groups |
| Molecular mass | About 813.9 g/mol | Average mass used for mass spectrometry confirmation |
| Appearance | White to off-white solid | Supplied as a lyophilised powder; hygroscopic |
| Solubility class | Freely soluble in aqueous media | Water, saline, and phosphate buffers; limited organic solubility |
| Typical storage temperature | -20 degrees Celsius | Long term and dry; short working periods may use 2 to 8 degrees Celsius |
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Within the immune system, prolactin acts to promote lymphocyte differentiation, proliferation, and function through the activation of protein kinase C signaling pathway. Prolactin has immunomodulatory and anti-inflammatory effects within the immune system, contributing to immune system maintenance. Stress also acutely stimulates prolactin production, as dopamine (a prolactin inhibitor) levels are reduced under stress, the pituitary gland is in turn expressed more leading to higher prolactin levels.
== References == Crowl, Philip A. (1995). The Pacific War: Campaign in the Marianas. United States Army in World War II. United States Army Center of Military History. ISBN 978-0-16-089915-7. LCCN 60-60000. Archived from the original on 21 July 2022. Retrieved 10 February 2017. Hoyt, Edwin Palmer (1986). Japan's War: The Great Pacific Conflict, 1853 to 1952. New York: McGraw-Hill. ISBN 0-07-030612-5. Morison, Samuel Eliot (1953). New Guinea and the Marianas, March 1944 – August 1944. History of United States Naval Operations in World War II. Vol. VIII. Little, Brown and Company. Polmar, Norman (2008). Aircraft Carriers: A History of Carrier Aviation and Its Influence on World Events, 1946–2006. Vol. II. Washington, D.C.: Potomac Books. pp. 377–400. ISBN 978-1-57488-665-8. Archived from the original on 21 July 2022. Retrieved 1 June 2014. Potter, E. B. (1990). Admiral Arleigh Burke. Naval Institute Press. ISBN 978-1-59114-692-6. Roscoe, Theodore (1949). Pig Boats. New York: Bantam Books. ISBN 978-0-553-13040-4. {{cite book}}: ISBN / Date incompatibility (help) Shaw, Henry I. Jr.; Nalty, Bernard C.; Turnbladh, Edwin T. (1966). "Strategic Victory in the Marianas Liberation of Guam; Capture of Saipan and Tinian". Central Pacific Drive (PDF). History of U.S. Marine Corps Operations in World War II. Vol. III. Historical Branch, G-3 Division, Headquarters, U.S. Marine Corps. Archived (PDF) from the original on 26 January 2021. Retrieved 25 November 2020. Shores, Christopher (1985). Duel for the Sky: Ten Crucial Battles of World War II. London: Grub Street. ISBN 978-0-7137-1601-6.
== Early life and education == Born in Preston, Lancashire in 1949, Halliwell was educated at Preston Grammar School. He attended St Catherine's College, University of Oxford (1968–71), achieving a BA with First Class (honours) in biochemistry. He was also awarded the Rose Prize for the best final papers of any candidate in biological sciences. His D.Phil in plant biochemistry was also at Oxford, supervised by Frederick R. Whatley and Vernon Butt; his thesis was entitled "The biochemistry of plant peroxisomes" (1973). He was later awarded a D.Sc from the University of London for his work on the biochemistry of free radical reactions in plant and animal systems.
Sources: en.wikipedia.org
== Slavery == The Global Slavery Index 2018, ranking the prevalence of modern slavery by nation, ranked Thailand 23 of 167 (1=worst; 167=best). The index claims that Thailand has 610,000 persons working in conditions of modern slavery, equating to 8.9 persons of every thousand. Other ASEAN nations ranked were: Cambodia, 9; Myanmar, 18; Brunei, 19; Laos, 22; Philippines, 30; Malaysia, 42; Indonesia, 74; Vietnam, 77; Singapore, 97. The Global Slavery Index 2016, published by the Walk Free Foundation, ranked Thailand 20 (tied with eight other countries) of 167 nations (1=worst) for the estimated percentage of its population in "modern slavery". ASEAN is well-represented in the index: Cambodia was ranked 2; Myanmar, 9; Brunei, 14; Malaysia, 29; Philippines, 33; Laos, 37; Indonesia, 39 (tied with one other country); Singapore, 45 (tied with one other country); and Vietnam, 47.
In John Gould's Handbook to the Birds of Australia, first published in 1865, he lamented the loss of the emu from Tasmania, where it had become rare and has since become extinct; he noted that emus were no longer common in the vicinity of Sydney and proposed that the species be given protected status. In the 1930s, emu killings in Western Australia peaked at 57,000, and culls were also mounted in Queensland during this period due to rampant crop damage. In the 1960s, bounties were still being paid in Western Australia for killing emus, but since then, wild emus have been granted formal protection under the Environment Protection and Biodiversity Conservation Act 1999. Their occurrence range is between 4,240,000 and 6,730,000 km2 (1,640,000–2,600,000 sq mi), and a 1992 census suggested that their total population was between 630,000 and 725,000. Their population trend is thought to be stable and the International Union for Conservation of Nature assesses their conservation status as being of least concern. The isolated emu population of the New South Wales North Coast Bioregion and Port Stephens is listed as endangered by the New South Wales Government. Although the population of emus on mainland Australia is thought to be higher now than it was before European settlement, some local populations are at risk of extinction. The threats faced by emus include the clearing and fragmentation of areas of suitable habitat, deliberate slaughter, collisions with vehicles and predation of the eggs and young.
=== Availability === Carbetocin has been approved for use under the following three brand names in 23 countries: Duratocin (Argentina, Australia, Bahrain, Canada, China, Hong Kong, Italy, Malaysia, Singapore, New Zealand), Lonactene (Mexico), and Pabal (Austria, Belgium, Switzerland, Germany, Estonia, France, United Kingdom, Hungary, Lithuania, Luxembourg, Finland). Duratocin has also been approved for veterinary use in Poland, Germany, Italy, Belgium, Luxembourg, France and the Netherlands. It is not available in the United States or Japan.
Sources: en.wikipedia.org
It is described as a synthetic analogue of the ACTH(4–10) fragment, a short segment of adrenocorticotropic hormone. Its sequence differs from that fragment and includes two proline residues, which influence stability and behaviour in solution.
It appears in Russian pharmaceutical listings as a nasal formulation, but it is not an authorised medicine in the United States or the European Union. Outside those markets it is normally encountered as a research chemical rather than a prescription product.
Laboratory and animal work points to melanocortin signalling and changes in neurotrophic factor levels, especially brain-derived neurotrophic factor. The exact receptor targets and the degree to which these findings transfer to humans are still unresolved.
Reversed-phase high-performance liquid chromatography is the standard method, with detection in the ultraviolet range. Peak area percentage yields a purity figure for the main component. Mass spectrometry is normally run alongside to confirm molecular identity.